R1	Subsumes Arg1:T4 Arg2:T5	
R2	Subsumes Arg1:T5 Arg2:T6	
R3	Has_value Arg1:T5 Arg2:T6	
R4	Has_value Arg1:T8 Arg2:T9	
*	OR T10 T11
R5	Subsumes Arg1:T8 Arg2:T10	
R6	Has_value Arg1:T10 Arg2:T12	
*	OR T8 T15 T16 T14
R7	Has_value Arg1:T17 Arg2:T18	
R8	AND Arg1:T20 Arg2:T21	
R9	Subsumes Arg1:T22 Arg2:T23	
T1	Condition 0 13	HIV infection
T2	Competing_trial 28 86	participation in previous or concurrent HIV vaccine trials
T3	Pregnancy_considerations 89 129	actating, pregnant or planning pregnancy
T4	Condition 131 156	renal function impairment
T5	Measurement 158 174	serum creatinine
T6	Value 175 185	>1.5 mg/dl
T7	Condition 188 204	Fanconi syndrome
T8	Measurement 215 235	liver function tests
T9	Value 206 214	abnormal
T10	Measurement 237 240	AST
T11	Measurement 241 244	ALT
T12	Value 245 253	> 43 U/L
T14	Condition 256 269	liver disease
T15	Condition 271 286	viral hepatitis
T16	Condition 288 321	hepatitis B virus (HBV) infection
T17	Measurement 323 339	serum phosphorus
T18	Value 340 349	<2.2mg/dl
T19	Condition 351 363	osteoporosis
T20	Condition 371 382	sensitivity
T21	Drug 404 411	Truvada
T22	Procedure 430 457	immunosuppressive treatment
T23	Drug 467 491	systemic corticosteroids
T24	Non-query-able 493 545	assumption of medication that interacts with Truvada
T25	Post-eligibility 548 610	high likelihood of poor adherence to PREP and clinic attendanc
T26	Non-query-able 613 771	any condition that in the opinion of the attending physician could endanger the health of the participant or render her unsuitable to participate in the trial
